Articles published in Journal of Diabetic Complications & Medicine have been cited by esteemed scholars and scientists all around the world.
Journal of Diabetic Complications & Medicine has got h-index 6, which means every article in Journal of Diabetic Complications & Medicine has got 6 average citations.
Following are the list of articles that have cited the articles published in Journal of Diabetic Complications & Medicine.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
40 | 25 | 32 | 30 | 23 | 3 | 6 |
Research, Review articles and Editorials |
4 | 1 | 2 | 7 | 17 | 0 | 6 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
36 | 24 | 30 | 23 | 6 | 0 | 0 |
Conference proceedings |
0 | 15 | 51 | 23 | 0 | 15 | 37 |
Citations received as per Google Scholar, other indexing platforms and portals |
127 | 89 | 16 | 18 | 13 | 13 | 7 |
Journal total citations count | 102 |
Journal impact factor | 2.05 |
Journal 5 years impact factor | 0.74 |
Journal cite score | 2.71 |
Journal h-index | 6 |
Journal h-index since 2019 | 4 |
Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes |
|
Stimulation of Hepatocyte Glucose Metabolism by Novel Small Molecule Glucokinase Activators |
|
Narrative Review: A Rational Approach to Starting Insulin Therapy |
|
Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion |
|
A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus |
|
Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1 |
|
Meglitinide analogues for type 2 diabetes mellitus |
|
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats |
|
PPAR-? agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis |
|
Is There a Role for ?-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus? |
|
Is There a Role for ?-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus? |
|
Is There a Role for ?-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus? |
|
Improving glucose management: Ten steps to get more patients with type 2 diabetes to glycaemic goal Recommendations from the Global Partnership for Effective Diabetes Management |
|
Anti-diabetic effect of ginsenoside Re in ob/ob mice |
|
Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs |
|
Effects of Oral Administration of Moringa oleifera Lam on Glucose Tolerance in Goto-Kakizaki and Wistar Rats |
|
Repaglinide A Review of its Therapeutic Use in Type 2 Diabetes Mellitus |
|
Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against ?-glucosidase and ?-amylase linked to type 2 diabetes |
|
Metformin Rapidly Increases Insulin Receptor Activation in Human Liver and Signals Preferentially through Insulin-Receptor Substrate-2 |
|
Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity |
|
Journal of Diabetic Complications & Medicine received 102 citations as per Google Scholar report